The FDA approved gabapentin enacarbil in 2011 as the first non-dopaminergic agent for the treatment of restless legs syndrome (RLS) symptoms. Although gabapentin enacarbil is a pro-drug of gabapentin, its pharmacokinetics differ. Restless legs syndrome (RLS) is a common disorder. The population prevalence is 1.5% to 2.7% in a subgroup of patients having more severe RLS with symptoms occurring 2 or more times a week and causing at least moderate distress. Gabapentin has been shown to improve RLS in a small number of clinical studies, but is limited by its short half-life and variable bioavailability. Gabapentin enacarbil is a novel prodrug of gabapentin designed to overcome these pharmacokinetic limitations. Gabapentin enacarbil available under the trade name Horizant is the only gabapentin product approved for treatment of Restless Legs Syndrome (RLS). A daily dose of 1200 mg provided no additional benefit compared with the 600 mg dose, but caused an increase in adverse reactions. Garcia-Borreguero, D., et al. “Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study.” Neurology 59.10 (2002): 1573-1579. Adler, Charles H. “Treatment of restless legs syndrome with gabapentin.” A. Gabapentin enacarbil (Horizant) has been approved by the FDA for the treatment of restless legs syndrome (RLS) and postherpetic neuralgia (the pain that can linger after a bout of shingles). It is different from plain gabapentin ( Neurontin or Gralise ). Diagnosis. To diagnose restless legs syndrome, your healthcare professional takes your medical history and asks about your symptoms. A diagnosis of RLS is based on the following criteria, established by the International Restless Legs Syndrome Study Group: Objective: To assess the effects of gabapentin on sensory and motor symptoms in patients with restless legs syndrome (RLS). Methods: Patients with RLS (22 idiopathic, 2 secondary to iron deficiency) were randomized and treated for 6 weeks with either gabapentin or placebo. To request a copy of the clinical practice guideline, “Treatment of restless legs syndrome and periodic limb movement disorder,” or the systematic review, meta-analysis, and GRADE assessment, or to arrange an interview with Dr. Winkelman or an AASM spokesperson, please contact the AASM at media@aasm.org. Accepted papers, which are published This article explains what gabapentin is, its approved and off-label uses, and how the drug works to treat restless legs syndrome and other medical conditions. It also describes the possible side effects and risks and lists other drugs and treatments that may help ease RLS symptoms. Gabapentin The use of gabapentin for restless legs syndrome (RLS) is off-label. Initial dose: 300 mg if the person is under 65 years old and 100 mg if the person is over 65 years old. Titration: maximum recommended dose for RLS is 2700 mg. CKS did not identify any specific guidance on dose Restless legs syndrome (RLS) is characterized by an urge to move the legs, usually in association with limb discomfort. 1 The symptoms occur at rest, are relieved by movement, and are worse in the evening and at night. Restless legs syndrome and cardiovascular disease: a research roadmap. Sleep Med. 2017;31:10–17. Crossref Google Scholar; 66. Migueis DP, Lopes MC, Casella E, Soares PV, Soster L, Spruyt K. Attention deficit hyperactivity disorder and restless leg syndrome across the lifespan: a systematic review and meta-analysis. Sleep Med Rev. 2023;69:101770. First-line management options include iron-replacement therapy in those with evidence for reduced body-iron stores or, alternatively, with prescribed gabapentin or pregabalin, and dopamine agonists such as pramipexole, ropinirole, and rotigotine. Restless legs syndrome (RLS) is a movement disorder that is described as an urge to move the legs or arms, commonly in response to an uncomfortable feeling. The urge to move has the following three features: • It is present at rest (sitting or lying down) • It is relieved (often only for a short time) by movement, especially walking
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |